Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
December 1, 2020
Precision Effect
“On average, a patient with a rare disease takes 4.8 years to find a correct diagnosis. For patients and families searching for answers, this wait can be agonizing. FDNA’s Face2Gene technology is helping to change the standard of care and shorten the time to diagnosis – all through the use of a smartphone.”
The article highlights the innovative use of FDNA technology in the realm of rare disease diagnosis, spotlighting its transformative potential. Employing advanced facial recognition algorithms, FDNA’s technology assists clinicians in identifying rare genetic disorders by analyzing patients’ facial features. This groundbreaking approach significantly enhances diagnostic accuracy and speed, offering a beacon of hope for individuals with elusive conditions. Through the lens of facial recognition in rare diseases, the article highlights the importance of integrating artificial intelligence into medical practice, thereby revolutionizing patient care and promoting timely, precise interventions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…